Connecting Balanced Health


Prescription Drugs

Prescription Drug

Pidommune Acid

Pidommune Powder

Active Ingredient / Strength

Ingredient Pidotimod 800mg

Indications

Immunostimulatory therapy for reduced cell-mediated immunity in respiratory infections

Shelf Life

24 months from the date of manufacture

Prescription Drug

Melo-D ODT 7.5mg

Melo-D ODT. 7.5mg

Active Ingredient / Strength

Ingredient Meloxicam 7.5mg

Indications

Short-term symptomatic treatment of acute exacerbations of osteoarthritis accompanied by pain and impaired mobility
Symptomatic treatment of rheumatoid arthritis and ankylosing spondylitis

Shelf Life

36 months from the date of manufacture

Prescription Drug

Melo-D ODT 15mg

Melo-D ODT. 15mg

Active Ingredient / Strength

Ingredient Meloxicam 15mg

Indications

Short-term symptomatic treatment of acute exacerbations of osteoarthritis accompanied by pain and impaired mobility
Symptomatic treatment of rheumatoid arthritis and ankylosing spondylitis

Shelf Life

36 months from the date of manufacture

Prescription Drug

Para K Inj. 75ml

Para K Inj. 75ml

Active Ingredient / Strength

Ingredient Acetaminophen 10mg/mL

Indications

For cases requiring rapid intravenous administration due to pain or high fever, or when administration by other routes is not possible
1. Short-term treatment of moderate pain (especially postoperative pain)
2. Short-term treatment of fever

Shelf Life

24 months from the date of manufacture

Prescription Drug

Zinc-in Inj. 15ml

Zinc-in Inj. 15ml

Active Ingredient / Strength

Ingredient Zinc Sulfate Hydrate 4.4mg/mL (as Zinc 1mg/mL)

Indications

Zinc supplementation during total parenteral nutrition (TPN)

Shelf Life

24 months from the date of manufacture

Prescription Drug

V-Tree Inj.

V-Tree Inj.

Active Ingredient / Strength

Ingredient Niacin 50mg/mL

Indications

1. Prevention and treatment of vitamin B3 deficiency, including pellagra
2. Supplementation when the demand for vitamin B3 is increased and dietary intake is insufficient, such as in wasting diseases, pregnancy, breastfeeding, and strenuous physical labor
3. In the following conditions, when vitamin B3 deficiency or metabolic disorder is presumed to be involved:
1) Angular cheilitis, stomatitis, glossitis
2) Contact dermatitis, acute and chronic eczema, photosensitive dermatitis
3) Meniere's syndrome
4) Peripheral circulatory disorders (Raynaud's phenomenon, cold extremities, chilblains, frostbite)
5) Tinnitus, hearing loss
6) Numbness associated with SMON (Subacute myelo-optico neuropathy)
(If the effect is insufficient in relation to item 3 above, it should not be used for longer than 1 month.)

Shelf Life

36 months from the date of manufacture

Prescription Drug

Isorel Inj.

Isorel Inj.

Active Ingredient / Strength

1mgViscum album (Abietis) 60mg aqueous extract 0.0167mL
6mgViscum album (Abietis) 60mg aqueous extract 0.1mL
12mgViscum album (Abietis) 60mg aqueous extract 0.2mL
24mgViscum album (Abietis) 60mg aqueous extract 0.4mL
36mgViscum album (Abietis) 60mg aqueous extract 0.6mL
60mgViscum album (Abietis) 60mg aqueous extract 1mL

Indications

Treatment of tumors, prevention of recurrence after tumor surgery, precancerous lesions, malignant diseases of the hematopoietic system, and stimulation of bone marrow function

Shelf Life

24 months from the date of manufacture